Total Payments
$22,054
2024 Payments
$3,037
Companies
33
Transactions
767
Medicare Patients
270
Medicare Billing
$144,558
Payment Breakdown by Category
Food & Beverage$21,911 (99.4%)
Education$143.11 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,911 | 756 | 99.4% |
| Education | $143.11 | 11 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $3,052 | 104 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $2,424 | 106 | $0 (2022) |
| ABBVIE INC. | $2,312 | 77 | $0 (2024) |
| Lundbeck LLC | $1,565 | 91 | $0 (2024) |
| Alkermes, Inc. | $1,486 | 38 | $0 (2024) |
| Allergan, Inc. | $1,367 | 33 | $0 (2020) |
| ITI, Inc. | $1,321 | 49 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,295 | 45 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $1,203 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $935.06 | 40 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,037 | 97 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($591.95) |
| 2023 | $3,482 | 108 | ABBVIE INC. ($881.90) |
| 2022 | $2,445 | 96 | ABBVIE INC. ($490.85) |
| 2021 | $2,667 | 103 | AbbVie Inc. ($545.45) |
| 2020 | $1,584 | 71 | Sunovion Pharmaceuticals Inc. ($431.02) |
| 2019 | $2,806 | 82 | Sunovion Pharmaceuticals Inc. ($751.28) |
| 2018 | $3,595 | 119 | Otsuka America Pharmaceutical, Inc. ($791.15) |
| 2017 | $2,439 | 91 | Otsuka America Pharmaceutical, Inc. ($808.59) |
All Payment Transactions
767 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $5.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: CNS | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: CNS | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $31.44 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/23/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $117.08 | General |
| Category: CNS | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CNS | ||||||
| 09/28/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $48.14 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 51 | 531 | $92,925 | $39,612 |
| 2022 | 1 | 56 | 564 | $98,700 | $42,778 |
| 2021 | 2 | 109 | 551 | $86,500 | $30,442 |
| 2020 | 1 | 54 | 510 | $63,900 | $31,726 |
Total Patients
270
Total Services
2,156
Medicare Billing
$144,558
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 531 | $92,925 | $39,612 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 564 | $98,700 | $42,778 | 43.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 55 | 397 | $59,550 | $19,407 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 154 | $26,950 | $11,036 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 510 | $63,900 | $31,726 | 49.6% |
About Dr. Won Gi Im, MD
Dr. Won Gi Im, MD is a Psychiatry healthcare provider based in Amityville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508932989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Won Gi Im, MD has received a total of $22,054 in payments from pharmaceutical and medical device companies, with $3,037 received in 2024. These payments were reported across 767 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($21,911).
As a Medicare-enrolled provider, Im has provided services to 270 Medicare beneficiaries, totaling 2,156 services with total Medicare billing of $144,558. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Amityville, NY
- Active Since 11/28/2006
- Last Updated 03/15/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508932989
Products in Payments
- REXULTI (Drug) $4,327
- VRAYLAR (Drug) $3,529
- LATUDA (Drug) $2,420
- CAPLYTA (Drug) $1,913
- INGREZZA (Drug) $1,203
- TRINTELLIX (Drug) $1,078
- ARISTADA (Drug) $901.63
- LYBALVI (Drug) $584.16
- Auvelity (Drug) $511.40
- INVEGA TRINZA (Drug) $496.32
- Adzenys XR-ODT (Drug) $439.83
- HETLIOZ (Drug) $426.41
- Trintellix (Drug) $371.56
- AUSTEDO (Drug) $339.30
- FANAPT (Drug) $326.01
- Austedo XR (Drug) $312.04
- MYDAYIS (Drug) $269.19
- QELBREE (Drug) $231.74
- SPRAVATO (Drug) $223.41
- INVEGA SUSTENNA (Drug) $198.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Amityville
Dr. Abid Khan, Md, MD
Psychiatry — Payments: $914,621
Psychiatry $914,621
Dr. Faisal Rafiq, M.d, M.D
Psychiatry — Payments: $106,745
Psychiatry $106,745
Kwang Lee, Md, MD
Psychiatry — Payments: $16,053
Psychiatry $16,053
Martin Calton, Md, MD
Psychiatry — Payments: $5,942
Psychiatry $5,942
Dr. Edward Sodaro, Md, MD
Psychiatry — Payments: $2,137
Psychiatry $2,137
Ejike Onuogu, Md, MD
Psychiatry — Payments: $2,100
Psychiatry $2,100